MedPath

Nova Laboratories Sdn Bhd.

Nova Laboratories Sdn Bhd. logo
🇲🇾Malaysia
Ownership
Private
Established
1989-01-01
Employees
1
Market Cap
-
Website
http://nova.my

Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease

Phase 2
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
Drug: Hepar-P
Drug: Placebo for Hepar-P
First Posted Date
2012-09-06
Last Posted Date
2013-04-12
Lead Sponsor
Nova Laboratories Sdn Bhd
Target Recruit Count
50
Registration Number
NCT01680003
Locations
🇲🇾

Tengku Ampuan Afzan Hospital, Kuantan, Pahang, Malaysia

🇲🇾

Kuala Lumpur Hospital, Wilayah Persekutuan, Kuala Lumpur, Malaysia

🇲🇾

Queen Elizaberth Hospital, Kota Kinabalu, Sabah, Malaysia

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath